Keytruda volumes by indication

The request was successful.

Dear The Dudley Group NHS Foundation Trust,

What volume of Keytruda (Pembrolizumab) is used for each of the following indications:

Lung Cancer, Renal Cell Carcinoma, Urothelial, melanoma head and neck.

I look forward to your response.

Yours faithfully,

BEN HOLDSWORTH

FOI (THE DUDLEY GROUP NHS FOUNDATION TRUST), The Dudley Group NHS Foundation Trust

2 Attachments

Good Morning

 

 

Please find attached acknowledgement of your request

 

 

Kind Regards

Information Governance Department

The Dudley Group NHS Foundation Trust

 

[1]cid:image004.jpg@01D10032.12C28DC0

 

 

 

 

 

If you are not the intended recipient of this email (and any attachment),
please inform the sender by return email and destroy all copies.
Unauthorised access, use, disclosure, storage or copying is not permitted.
Communication by internet email is not secure as messages can be
intercepted and read by someone else. Therefore we strongly advise you not
to email any information, which if disclosed to unrelated third parties
would be likely to cause you distress. If you have an enquiry of this
nature please provide a postal address to allow us to communicate with you
in a more secure way. If you want us to respond by email you must realise
that there can be no guarantee of privacy.
Any email including its content may be monitored and used by the Trust for
reasons of security and for monitoring internal compliance with Trust
policy on staff use. Email monitoring or blocking software may also be
used. Please be aware that you have a responsibility to ensure that any
email you write or forward is within the bounds of the law.
The Trust cannot guarantee that this message or any attachment is virus
free or has not been intercepted and amended. You should perform your own
virus checks.

 

 

 

 

 

 

 

 

 

 

 

show quoted sections

FOI (THE DUDLEY GROUP NHS FOUNDATION TRUST), The Dudley Group NHS Foundation Trust

2 Attachments

Good Morning

 

 

Please find attached response to your request.

 

 

 

Kind Regards

Information Governance Department

The Dudley Group NHS Foundation Trust

 

[1]cid:image004.jpg@01D10032.12C28DC0

 

 

 

 

 

 

 

 

 

If you are not the intended recipient of this email (and any attachment),
please inform the sender by return email and destroy all copies.
Unauthorised access, use, disclosure, storage or copying is not permitted.
Communication by internet email is not secure as messages can be
intercepted and read by someone else. Therefore we strongly advise you not
to email any information, which if disclosed to unrelated third parties
would be likely to cause you distress. If you have an enquiry of this
nature please provide a postal address to allow us to communicate with you
in a more secure way. If you want us to respond by email you must realise
that there can be no guarantee of privacy.
Any email including its content may be monitored and used by the Trust for
reasons of security and for monitoring internal compliance with Trust
policy on staff use. Email monitoring or blocking software may also be
used. Please be aware that you have a responsibility to ensure that any
email you write or forward is within the bounds of the law.
The Trust cannot guarantee that this message or any attachment is virus
free or has not been intercepted and amended. You should perform your own
virus checks.

 

 

 

 

 

 

 

 

 

 

 

show quoted sections